✦ LIBER ✦

Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients With c-Kit–Positive, Extensive-Stage Small-Cell Lung Cancer

✍ Scribed by Bryan J. Schneider; Gregory P. Kalemkerian; Nithya Ramnath; Michael J. Kraut; Antoinette J. Wozniak; Francis P. Worden; John C. Ruckdeschel; Xiaohui Zhang; Wei Chen; Shirish M. Gadgeel

Book ID: 119935644
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 116 KB
Volume: 11
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2010.n.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III Trial of Cisplatin/

Randomized Phase III Trial of Cisplatin/Irinotecan Versus Cisplatin/Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer

✍ Primo N. Lara Jr; David R. Gandara; Ronald B. Natale 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 462 KB

A phase II study of biweekly irinotecan

A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer

✍ Bae, Sung Hwa; Ryoo, Hun Mo; Do, Young Rok; Song, Hong Suk; Kwon, Ki Young; Kim, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

1168 PUBLICATION A phase II study of biw

1168 PUBLICATION A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II trial of thalidomide as mainten

Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy

✍ Dowlati, Afshin; Subbiah, Shanmuga; Cooney, Matthew; Rutherford, Kimberly; Mekha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Phase II trial of Sorafenib in conjuncti

Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer

✍ Sharma, Neelesh; Pennell, Nathan; Nickolich, Myles; Halmos, Balazs; Ma, Patrick; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 194 KB

O-156 Randomized, phase III trial compar

O-156 Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)

✍ Langer, C.; Hanna, N.; Einhorn, L.; Sandler, A.; Ansari, R.; Ellis, P.; Byrne, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 278 KB